Back to FIRST TRUST ADVISORS LP FIRST TRUST ADVISORS LP

KRYSKRYS
8 quarters

Position history for FIRST TRUST ADVISORS LPFIRST TRUST ADVISORS LP's holdings in KRYSTAL BIOTECH INC

Yes. First Trust holds 324,900 shares of KRYS (Krystal Biotech), worth $120.8M, as of its Q2 2026 13F filing. It reduced the position by 25,621 shares (-7.3%) from Q1 2026. First Trust has held KRYS since Q3 2024, across 8 quarterly 13F filings. KRYS is 0.1% of First Trust's reported 13F portfolio.

Current Value

$120.8M

Current Shares

324,900

Total Value Change

+$113.6M

Total Shares Change

+285,489

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
324,900
-7.3%
$120.8M0.1%$371.67
0
2026-Q1
Increased
350,521
+42.9%
$90.5M0.1%$263.80
40
2025-Q4
Decreased
245,276
-1.3%
$60.5M0.0%$247.88
0
2025-Q3
Increased
248,392
+11.7%
$43.8M0.0%$176.75
33
2025-Q2
Increased
222,370
+571.3%
$30.6M0.0%$138.88
46
2025-Q1
Increased
33,125
+43.0%
$6M0.0%$183.92
36
2024-Q4
Decreased
23,169
-41.2%
$3.6M0.0%$159.80
0
2024-Q3
New
39,411
-
$7.2M0.0%$177.14
38

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used